Video tumor board for skin cancer patients
Part of Cancer, Skin clinical trials.
This trial tests a video-based tumor board where doctors discuss difficult skin cancer cases. It aims to help patients who are being treated outside the main cancer center get expert advice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a skin cancer diagnosis, such as advanced melanoma, rare skin tumors, or complex skin cancers
- You are being treated at a clinic outside the main cancer center
- You can understand and agree to the study rules
- Your doctor agrees to join the video tumor board
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
This trial sets up a “molecular tumor board,” a team that reviews your tumor’s lab results and helps your doctor choose treatment options. It may help by making sense of tumor test findings so decisions are more personalized.
This study tests if video consultations can safely check skin side effects from chemotherapy or other cancer drugs. If you have a mild to moderate skin rash or reaction, you might be able to have a telemedicine visit instead of going to the hospital.
This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.
This study compares two systems that take pictures of your whole skin to find melanoma early. You might qualify if you have a higher risk for melanoma, such as having had melanoma before, many moles, or a strong family history.
This study tests whether telemedicine (video or phone calls) can help people with advanced cancer and their caregivers. You and a family member or friend will join telemedicine sessions to get support and manage your needs.
Hear when a new Malignant Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.